IOL Chemicals and Pharmaceuticals Limited (BOM:524164)

BOM:524164 Revenue

IOL Chemicals and Pharmaceuticals had revenue of 7.56B INR in the quarter ending June 30, 2026, with 37.08% growth. This brings the company's revenue in the last twelve months to 25.24B, up 18.56% year-over-year. In the fiscal year ending March 31, 2026, IOL Chemicals and Pharmaceuticals had annual revenue of 23.19B with 11.54% growth.

• Revenue (ttm): 25.24B
• Revenue Growth: +18.56%
• P/S Ratio: 1.97
• Revenue / Employee: 8.15M
• Employees: 3,095
• Market Cap: 49.77B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	23.19B	2.40B	11.54%
Mar 31, 2025	20.79B	-535.80M	-2.51%
Mar 31, 2024	21.33B	-843.20M	-3.80%
Mar 31, 2023	22.17B	330.90M	1.52%
Mar 31, 2022	21.84B	2.17B	11.03%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error